NF
AMPE

NTB Financial’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

NTB Financial’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$16K Sell
322
-165
-34% -$12.3K 0.01% 143
2022
Q1 		$69K Hold
487
– – 0.05% 151
2021
Q4 		$83K Buy
+487
New +$182K 0.06% 144

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NTB Financial's AMPE Position: Q2 2022 in Review

NTB Financial reduced its Ampio Pharmaceuticals Inc. (AMPE) stake by 34% in Q2 2022, selling an estimated $12.3K and leaving 322 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #143.

NTB Financial first reported a position in AMPE in Q4 2021 and has held it in 3 quarters since. The position peaked at $83K in Q4 2021. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • NTB Financial held 322 shares of Ampio Pharmaceuticals Inc. worth $16K as of Q2 2022.
  • NTB Financial sold 165 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $12.3K.
  • Ampio Pharmaceuticals Inc. made up 0.01% of NTB Financial's portfolio in Q2 2022, its #143 holding.
  • NTB Financial first reported a position in Ampio Pharmaceuticals Inc. in Q4 2021 and has held it in 3 quarters since.
  • NTB Financial's Ampio Pharmaceuticals Inc. position peaked at $83K in Q4 2021.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on NTB Financial's 13F filing for Q2 2022, filed 9 Aug 2022.